Answers are grounded in this paper and cite their sources.
precursor or its substrate α-ketoglutarate or treatment with a poly(ADP ribose) polymerase inhibitor protects reductive carboxylation and RPE viability from excessive oxidative stress. The ability of these treatments to rescue RPE could be the basis for an effective strategy to treat blinding diseases caused by RPE dysfunction.
No takes yet. Share an insight, caveat, or question.
Du et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: